Net Cash Provided by (Used in) Operating Activities |
-265 K |
USD |
+55.1% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-555 K |
USD |
+99.7% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
604 K |
USD |
-99.6% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
7.29 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-216 K |
USD |
-198% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
701 K |
USD |
+37.1% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
701 K |
USD |
+37.1% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
-190 K |
USD |
-4.42% |
Dec 31, 2023 |
2023 |
Preferred Stock, Shares Authorized |
1 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
214 K |
USD |
-36.5% |
Jun 30, 2022 |
Q2 2022 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
799 K |
USD |
+12.5% |
Dec 31, 2023 |
2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |